Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

2024
Pharmaceuticals

Therapeutic Area

Glaucoma
Categories

Other

Affiliations

Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Nara, 630-0101, Japan; Ophthalmology Innovation Center, Santen Inc., Emeryville, 94608, CA, United States; Institute of Ophthalmology, University College London, London, WC1E 6BT, United Kingdom; Imperial College of Science and Technology, St. Mary’s Campus, London, SW7 2AZ, United Kingdom; Eye-APC Duke-NUS Medical School, Singapore, 169857, Singapore; Department of Pharmacy Sciences, Creighton University, Omaha, 68178, NE, United States; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, 77004, TX, United States; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, 76107, TX, United States; Singapore Eye Research Institute, Singapore, 169856, Singapore; Global Research and Development, Nanoscope Therapeutics Inc., Dallas, 75207, TX, United States; EyeCRO LLC, Oklahoma City, 73105, OK, United States

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.